#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prolymphocytic leukaemia Ovarian cancer stage IV Mucopolysaccharidosis III Inborn error of metabolism Metastatic malignant melanoma Wolfram syndrome General anaesthesia Craniocerebral injury Adrenoleukodystrophy Craniopharyngioma Hepatitis B Juvenile idiopathic arthritis Pemphigus Lupus nephritis Haemolytic uraemic syndrome More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Basic Information Angiosarcoma metastatic Soft tissue sarcoma – Trials in Disease Lysosomal storage disorder – Basic Information Uterine leiomyosarcoma – Basic Information Hereditary angioedema – Basic Information Mucopolysaccharidosis III – Basic Information Mucopolysaccharidosis III – Trials in Disease Amyotrophic lateral sclerosis – Treatment Hereditary optic atrophy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ALENDRONATE SODIUM TRIHYDRATE SECRETIN SYNTHETIC HUMAN Regn5668 Prilocaine GSKVX000000070250 Piflufolastat (18F) Clozapine Brexpiprazole Omp66 SODIUM FUSIDATE CAL101 Divarasib Tipiracil Sodium Iodide (123 I) PEGZILARGINASE Fluorescein Sodium Phleum Pratense (225) Ziprasidone Methoxsalen D-Biotin More therapies…

    Learn about Your Condition

    Somatic symptom disorder Craniopharyngioma Metastases to lymph nodes Hairy cell leukaemia recurrent Endocarditis Hypocalcaemia Bacterial vaginosis Prader-Willi syndrome Tympanic membrane hyperaemia Encephalitis autoimmune Hypoparathyroidism Short stature Mitochondrial myopathy Colorectal adenocarcinoma Malignant neoplasm of choroid More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study on Patiromer and Placebo for Managing Hyperkalemia in Non-Dialysis Patients with Chronic Kidney Disease Stages IIIB to V

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hyperkalaemia
    Investigated Drugs:
    • Calcium Polystyrene Sulfonate
    • Iohexol
    • Patiromer
    Italy

  • Study on the Effect of Patiromer on Vascular Health in Patients with Chronic Kidney Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Patiromer
    Spain

  • Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Sulfonamides, Urea Derivatives
    • Canagliflozin
    • Insulin Glargine
    Austria Czechia Germany Greece Italy Romania +2

  • Study on Linaclotide for Treating Functional Constipation in Children Aged 2 to 5 Years

    Not recruiting

    3 1
    Investigated Diseases:
    • Constipation
    Investigated Drugs:
    • Linaclotide
    Bulgaria The Netherlands

  • Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Efinopegdutide
    • Semaglutide
    Austria Belgium Czechia France Hungary Italy +2

  • Study on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Obesity
    Investigated Drugs:
    • Ly3437943 Sodium
    Hungary Poland Slovakia Spain
Previous Page
1 … 61 62 63 64 65 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!